A comprehensive systematic review of the types of medication classes targeted by deprescribing tools and the tools/interventions applied to each class
Madanat, Faisal and Noorsaeed, Solafa and Alkhlaifat, Rahaf and Mueller, Tanja and Kurdi, Amanj (2025) A comprehensive systematic review of the types of medication classes targeted by deprescribing tools and the tools/interventions applied to each class. Expert Review of Clinical Pharmacology. ISSN 1751-2441 (https://doi.org/10.1080/17512433.2025.2585449)
Preview |
Text.
Filename: Madanat-etal-ERCP-2025-A-comprehensive-systematic-review-of-types-of-medication-classes.pdf
Final Published Version License:
Download (6MB)| Preview |
Abstract
Introduction: Polypharmacy and potentially inappropriate medications (PIMs) contribute to adverse outcomes. Deprescribing, the supervised withdrawal of PIMs, is a key strategy to reduce these risks. Identifying the most targeted PIMs and commonly used tools for deprescribing remains essential. The aim of this systematic review was to identify the medication classes targeted by deprescribing tools, stratified by tool type and frequency and to evaluate the availability of medication-specific tools. Methods: A systematic search of Embase, PubMed, Scopus, and Medline (2010–2023) identified observational and experimental studies using polypharmacy and deprescribing terms. The Newcastle-Ottawa Scale (NOS) and the revised Cochrane risk-of-bias tool (RoB 2) were used for quality assessment. Medication classes and tools/interventions were summarized in the TOTALLY TARGETED List. Results: Eighty-two studies identified 44 deprescribing tools targeting 77 medication classes. The top PIMs were benzodiazepines, antipsychotics, alpha-receptor blockers, proton pump inhibitors, and Z-hypnotics. The most used tools were Screening Tool of Older People’s Prescriptions (STOPP) Frail, American Geriatric Society (AGS) Beers Criteria, STOPP Criteria, and STOPPFall. Several medication-specific tools (e.g. PIMs in cognitively impaired patients) were also identified. Conclusion: This review identified the most targeted medication classes and deprescribing tools, emphasizing the need for medication-specific and patient-centered approaches to improve safety and outcomes. Protocol registration: https://www.crd.york.ac.uk/prospero//CRD42023442654.
ORCID iDs
Madanat, Faisal
ORCID: https://orcid.org/0009-0008-6950-2208, Noorsaeed, Solafa, Alkhlaifat, Rahaf
ORCID: https://orcid.org/0000-0002-7007-3534, Mueller, Tanja
ORCID: https://orcid.org/0000-0002-0418-4789 and Kurdi, Amanj
ORCID: https://orcid.org/0000-0001-5036-1988;
-
-
Item type: Article ID code: 94626 Dates: DateEvent10 November 2025Published10 November 2025Published Online2 November 2025AcceptedSubjects: Medicine > Therapeutics. Pharmacology Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
Strategic Research Themes > Health and WellbeingDepositing user: Pure Administrator Date deposited: 03 Nov 2025 12:57 Last modified: 11 Dec 2025 01:26 URI: https://strathprints.strath.ac.uk/id/eprint/94626
Tools
Tools






